The First Haerbin Psychiatric Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xu, Jia
NCT04536337: A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Recruiting
1
336
Europe, RoW
ALG-000184, Placebo, Entecavir
Aligos Therapeutics
Chronic Hepatitis B
11/23
06/24
NCT06693973: An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Recruiting
1
13
RoW
AcNK-Sup003 cell injection solution
Wuhan Union Hospital, China, SupermAb (BeiJing) Biotech Co., Ltd
B-cell Non-Hodgkin Lymphoma (B-NHL)
01/26
01/26
NCT06691685: A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.

Recruiting
1
24
RoW
ESO-T01 Injection
Wuhan Union Hospital, China, Shenzhen Pregene Biopharma Co., Ltd.
Multiple Myeloma
11/27
11/27
NCT05924308: Acupuncture Therapy for Post-stroke Mild Cognitive Impairment: a Randomized Controlled Trial

Recruiting
N/A
60
RoW
electroacupuncture, sham acupuncture
Shanghai University of Traditional Chinese Medicine
Post-stroke Mild Cognitive Impairment
03/24
05/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xu, Jia
NCT04536337: A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Recruiting
1
336
Europe, RoW
ALG-000184, Placebo, Entecavir
Aligos Therapeutics
Chronic Hepatitis B
11/23
06/24
NCT06693973: An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Recruiting
1
13
RoW
AcNK-Sup003 cell injection solution
Wuhan Union Hospital, China, SupermAb (BeiJing) Biotech Co., Ltd
B-cell Non-Hodgkin Lymphoma (B-NHL)
01/26
01/26
NCT06691685: A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.

Recruiting
1
24
RoW
ESO-T01 Injection
Wuhan Union Hospital, China, Shenzhen Pregene Biopharma Co., Ltd.
Multiple Myeloma
11/27
11/27
NCT05924308: Acupuncture Therapy for Post-stroke Mild Cognitive Impairment: a Randomized Controlled Trial

Recruiting
N/A
60
RoW
electroacupuncture, sham acupuncture
Shanghai University of Traditional Chinese Medicine
Post-stroke Mild Cognitive Impairment
03/24
05/25

Download Options